Transmyocardial revascularization [TMR] versus medical treatment in patients with exensive coronary artery disease [12 months follow-up]
New Egyptian Journal of Medicine [The]. 2002; 27 (Supp. 6): 93-97
in English
| IMEMR
| ID: emr-60342
ABSTRACT
The aim of this study was to compare the efficacy of TMR versus medical management in cases of severe CAD not amenable to percutaneous transluminal coronary angioplasty [PTCA] or coronary artery bypass grafting [CABG]. Sixty-six patients with severe CAD were treated randomly, either by TMR or medical treatment. Accordingly, they were divided into two groups Group 1 included 26 patients who were treated medically, while group 2 included 40 patients who were treated by TMR. All patients were subjected to clinical assessment and stress-redistribution-reinjection [ST-KD-RI] Thallium SPECT protocol pre and post TMR [3, 6, 9 and 12 months]. The study concluded that TMR has been proved to be effective in the management of severe cases of CAD concerning the quality of life and survival. Transmyocardial revascularization is a treatment option for patients with medically refractory angina who are not candidates for conventional revascularization
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Postoperative Complications
/
Severity of Illness Index
/
Follow-Up Studies
/
Treatment Outcome
/
Coronary Disease
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
New Egypt. J. Med.
Year:
2002
Similar
MEDLINE
...
LILACS
LIS